ArticleFrontiers in oncology2019

Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pancreatic Cancer.

Chen-Yu Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.